In this Review, the authors discuss current immunotherapy, targeted therapy and gene therapy and propose a synergistic model of combination therapy for prostate cancer, which could enhance the effectiveness of these treatments.
- Xuanji Li
- Zeyu Han
- Jianzhong Ai